Genflow Biosciences annual total assets
2021
2022
2023
2024
2025
Genflow Biosciences Total Assets Growth & History (GENF)
Genflow Biosciences's total assets was £452,386 for fiscal 2025.
View full Genflow Biosciences company overviewGenflow Biosciences annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | £452,386 | £66,478 | +17.23% |
| 2024 | 2024-12-31 | £385,908 | −£685,745 | −63.99% |
| 2023 | 2023-12-31 | £1.1M | −£1.5M | −59.06% |
| 2022 | 2022-12-31 | £2.6M | £2.3M | +846.47% |
| 2021 | 2021-12-31 | £276,551 | — | — |
Genflow Biosciences quarterly total assets
Q4.24
Q2.25
Q4.25
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | £452,386 | £66,478 | +17.23% |
| Q2 2025 | 2025-06-30 | £468,381 | — | — |
| Q4 2024 | 2024-12-31 | £385,908 | — | — |
Genflow Biosciences total assets trends
Between the periods ended 2021-12-31 and 2025-12-31, Genflow Biosciences's total assets increased from £276,551 to £452,386, a change of £175,835. The latest reported quarter, Q4 2025, shows £452,386.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
reported total assets
TickerStat uses total assets reported in company official filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Genflow Biosciences source filings ↗